In colorectal and breast cancers, Cdx2 is known as a tumor suppressor that antagonizes cancer metastasis by inhibiting cell migration (Gross et al., 2008; Wang et al., 2020; Yu et al., 2021). Here, CDX2 is linked to cancer.